Most attention has been focused on KL-6 as a diagnostic and prognostic tool in ARDS, interstitial lung diseases, hypersensitivity pneumonitis, and collagen vascular disease-associated interstitial pneumonitis [7–9]. This evidence concerns the gene MUC1 and interstitial lung disease.